$0.06
(1.03%)
Add to watchlist
Create an alert
Stocks and Shares ISAExicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Company Information
About this company
Key people
Josephine Cardarelli
President, Chief Scientific Officer
Andy Yoo
Chief Executive Officer, Director
Seung Ik Baik
Chief Financial Officer, Secretary, Director
Aejin Hwang
Independent Director
Dongho Lee
Independent Director
Sangjn Yeo
Independent Director
Click to see more
Key facts
- Shares in issue6.37m
- EPICXCUR
- ISINUS30205M3097
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$37.54m
- Employees8
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.